Stock Analysis

KRX Growth Stocks With High Insider Ownership In October 2024

Published

Over the last seven days, the South Korean market has remained flat, yet it has seen a 7.3% rise over the past year with earnings anticipated to grow by 29% annually in the coming years. In this context of steady growth and promising future earnings, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.4%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.7%49.1%
HANA Micron (KOSDAQ:A067310)18.3%105.8%
Bioneer (KOSDAQ:A064550)15.8%97.6%
Oscotec (KOSDAQ:A039200)26.1%122%
ALTEOGEN (KOSDAQ:A196170)26.6%99.5%
Vuno (KOSDAQ:A338220)19.4%110.9%
Park Systems (KOSDAQ:A140860)33%34.6%
UTI (KOSDAQ:A179900)33.1%134.6%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 88 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

Medy-Tox (KOSDAQ:A086900)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medy-Tox Inc. is a South Korean biopharmaceutical company with a market cap of ₩1.17 trillion.

Operations: The company's revenue from its biotechnology segment is ₩246.25 billion.

Insider Ownership: 19.8%

Earnings Growth Forecast: 62% p.a.

Medy-Tox is experiencing significant earnings growth, forecasted at 62% annually, surpassing the South Korean market's average. Despite a decline in profit margins from last year, the stock trades significantly below its estimated fair value. Analysts agree on a potential price increase of 48.3%. The company has announced a share buyback program to stabilize stock prices and enhance shareholder value, reflecting strong insider confidence despite no recent substantial insider trading activity.

KOSDAQ:A086900 Ownership Breakdown as at Oct 2024

SungEel HiTech (KOSDAQ:A365340)

Simply Wall St Growth Rating: ★★★★★☆

Overview: SungEel HiTech Co., Ltd. is a South Korean company specializing in secondary battery recycling, with a market cap of ₩656.63 billion.

Operations: The company's revenue is primarily generated from its Secondary Battery Raw Material Manufacturing segment, totaling ₩196.64 billion.

Insider Ownership: 38%

Earnings Growth Forecast: 101.7% p.a.

SungEel HiTech is forecasted to achieve substantial revenue growth of 40% annually, significantly outpacing the South Korean market average. Although its return on equity is expected to remain low at 9.5% in three years, the company trades at a significant discount to its estimated fair value. Despite no substantial insider trading activity recently, SungEel HiTech's anticipated profitability within three years signals potential for robust financial performance amidst current debt challenges.

KOSDAQ:A365340 Ownership Breakdown as at Oct 2024

APR (KOSE:A278470)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: APR Co., Ltd is a company that manufactures and sells cosmetic products for men and women, with a market cap of ₩403.58 billion.

Operations: The company's revenue is primarily derived from its cosmetics segment, generating ₩614.77 billion, complemented by its apparel fashion segment with ₩64.46 billion.

Insider Ownership: 32.8%

Earnings Growth Forecast: 22.8% p.a.

APR Co., Ltd. is experiencing significant earnings growth, expected to rise 22.77% annually over the next three years, although revenue growth of 19.6% per year is slightly below the desired threshold for high-growth companies. The company recently completed a share buyback and has been added to the S&P Global BMI Index, enhancing its market visibility. Despite high share price volatility, APR trades at a discount to its fair value with no recent insider trading activity noted.

KOSE:A278470 Earnings and Revenue Growth as at Oct 2024

Key Takeaways

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com